Myriad™ Augmented Soft Tissue Reconstruction Registry

RecruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

January 10, 2022

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2029

Conditions
Abdominal Wound DehiscenceNecrotizing Soft Tissue InfectionLower Extremity WoundPilonidal SinusAnal FistulaHidradenitis SuppurativaPressure Injury
Interventions
DEVICE

Myriad Matrix™ and Myriad Morcells™

Ovine forestomach matrix sheet graft and morselized extracellular matrix

Trial Locations (11)

12601

ENROLLING_BY_INVITATION

Nuvance Health Vassar Brothers Medical Center, Poughkeepsie

19611

ENROLLING_BY_INVITATION

Tower Health Reading Hospital, West Reading

21215

RECRUITING

Sinai Hospital of Baltimore, Baltimore

30501

RECRUITING

Northeast Georgia Medical Center, Inc., Gainesville

32504

RECRUITING

Asencion Sacred Heart, Pensacola

33919

ACTIVE_NOT_RECRUITING

Associates in Medicine & Surgery, Fort Myers

43210

ENROLLING_BY_INVITATION

Ohio State University Wexner Medical Center, Columbus

70112

RECRUITING

University Medical Center, New Orleans

70115

ENROLLING_BY_INVITATION

Ochsner Baptist Medical Center, New Orleans

90048

RECRUITING

Surgery Group LA, Los Angeles

27401-1004

ENROLLING_BY_INVITATION

Moses H Cone Memorial Hospital Operating Corporation, Greensboro

Sponsors
All Listed Sponsors
lead

Aroa Biosurgery Limited

INDUSTRY

NCT05243966 - Myriad™ Augmented Soft Tissue Reconstruction Registry | Biotech Hunter | Biotech Hunter